CLEARSIDE BIOMEDICAL INC. news, videos and press releases
For more news please use our advanced search feature.
CLEARSIDE BIOMEDICAL INC. - More news...
CLEARSIDE BIOMEDICAL INC. - More news...
- Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical?
- Thinking about buying stock in Digital Turbine, Purple Innovation, Clearside Biomedical, Rivian Automotive, or ZipRecruiter?
- Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners?
- Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
- Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
- Thinking about buying stock in Clearside Biomedical, Uxin, Petco Health and Wellness, Ashford Hospitality Trust, or Uber?
- Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 01-29-2020
- Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 01-06-2020
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 01-02-2020
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 12-31-2019
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 12-24-2019
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 12-16-2019
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 12-02-2019
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 11-27-2019
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 10-23-2019
- Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 10-03-2019
- REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 08-08-2019
- Clearside Biomedical, Inc. - CLSD Stock Chart Technical Analysis for 02-20-2019
- Clearside Biomedical, Inc. to Host Earnings Call
- Investor Network: Clearside Biomedical, Inc. to Host Earnings Call
- Investor Network: Clearside Biomedical, Inc. to Host Earnings Call
- Clearside Biomedical, Inc. Receives Notice of Allowance for Seventh U.S. Patent
- Clearside Biomedical, Inc. to Present at J.P. Morgan Healthcare Conference
- Clearside Biomedical, Inc. Appoints Richard Beckman, M.D., as Chief Medical Officer
- Clearside Biomedical, Inc. Added to NASDAQ Biotechnology Index
- Clearside Biomedical, Inc. Announces Pricing of Public Offering of Common Stock